Previous close | 75.31 |
Open | 75.04 |
Bid | 74.86 x 900 |
Ask | 74.89 x 1400 |
Day's range | 74.29 - 75.52 |
52-week range | 61.05 - 138.47 |
Volume | |
Avg. volume | 527,219 |
Market cap | 2.319B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 28.79 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.80 (1.06%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
Key Insights CONMED's estimated fair value is US$142 based on 2 Stage Free Cash Flow to Equity CONMED is estimated to...
In this article, we will take a detailed look at the 10 Worst-Performing Stocks Insiders are Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Worst-Performing Stocks Insiders are Buying in 2024. Expert money managers and investors have always advised individual investors to not fret over […]
On April 30, 2024, Pat Beyer, Chief Operating Officer of Conmed Corp (NYSE:CNMD), purchased 3,000 shares of the company, as reported in a recent SEC Filing.